Overview
One‑of‑a‑Kind Partnership
The Gene Therapy Initiative at UC San Diego, California Life Sciences and CIRM converge in La Jolla, CA – September 16 & 17 to discuss the Future of Cell & Gene Therapy.
All‑Encompassing Agendas
Each day stands on its own, so participants can choose to attend one or attend both. The program is built for everyone working in this space across Southern California, across therapeutics, manufacturing, research, capital, and the legal and policy infrastructure that supports the field.
Who Should Attend:
The Gene Therapy Initiative at UC San Diego, California Life Sciences and CIRM converge in La Jolla, CA – September 16 & 17 to discuss the Future of Cell & Gene Therapy.
All‑Encompassing Agendas
- Day 1, hosted by UC San Diego GTI, features academic and industry leaders showcasing cutting‑edge cell‑based safety models, ex‑vivo and in‑vivo genetic therapy technologies, and bold bench‑to‑bedside strategies.
- Day 2, hosted by CLS and CIRM, features panels on scientific innovation, manufacturing, patient delivery, and commercialization.
Each day stands on its own, so participants can choose to attend one or attend both. The program is built for everyone working in this space across Southern California, across therapeutics, manufacturing, research, capital, and the legal and policy infrastructure that supports the field.
Who Should Attend:
- Academic researchers and post‑doctoral fellows in cell & gene therapy
- Biotech and pharmaceutical scientists, project managers, and business development professionals
- Investors, venture‑capital partners, entrepreneurs, and industry consultants
- Regulatory affairs, quality & manufacturing specialists
Day 1 | Gene Therapy Initiative
Wednesday - September 16, 2026
Questions? Contact us at GTI_admin@health.ucsd.edu or (858) 534‑5207
Featuring: 
Day 2 | California Life Sciences x CIRM
Thursday - September 17, 2026
Salk Institute for Biological Studies
The Conrad T. Prebys Auditorium
10010 N. Torrey Pines Rd
La Jolla, CA 92037